Serbia will make a drug for SMA: It will be cheaper and more effective than Zolgensma
The development of the cheaper and more effective drug to alleviate the symptoms of spinal muscular atrophy in infants is the goal of the SMAIPROTACs project.
I highly doubt the West is interested in using the “drug” to by produced Serbia. Any nation not a member of the EU cannot expect EU member countries to procure the Serbian “drug.”
I highly doubt the West is interested in using the “drug” to by produced Serbia. Any nation not a member of the EU cannot expect EU member countries to procure the Serbian “drug.”
I highly doubt the West is interested in using the “drug” to by produced Serbia. Any nation not a member of the EU cannot expect EU member countries to procure the Serbian “drug.”
IMAGE SOURCE
1 Komentari
Sortiraj po: